October 18, 2010 — Certain syringes manufactured by Excelsior Medical are subject to a class 1 recall because of a potential loss of sterility, the US Food and Drug Administration (FDA) announced ...
Becton, Dickinson and Co. will invest more than $110M to expand a Nebraska syringe facility, add 120 jobs and support ...
BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...
WASHINGTON, Aug. 20 (UPI) -- Covidien, a healthcare products producer, initiated a voluntary recall of certain lots of Monoject prefill flush syringes, U.S. government officials say. The U.S. Food and ...
FRANKLIN LAKES, N.J., Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million ...
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area with seven hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, ...
Global IV Flush Syringe Market is valued at approximately USD $$ million in 2022 and is anticipated to grow with a healthy growth rate of more than $% over the forecast period 2023-2031. Request To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback